AbbVie expects acquisition to cut 2027 adj EPS by about 46c
AbbVie expects the acquisition to negatively impact 2027 adjusted EPS by about 46c, with accretion beginning in 2032.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.